[The use of the preparation Lomir in patients with arterial hypertension and postinfarct cardiosclerosis].
As many as 26 patients with arterial hypertension (AH) associated with postmyocardial infarction cardiosclerosis were examined for assessing the efficacy of a new preparation belonging to a panel of calcium antagonists, viz. isradipine (<<Lomir>> by SANDOZ). Of note, a positive result was observed in 88%, which fact was manifested by normalization of AH without any side effects. Half the patient population showed improved tolerability of physical loads by lowering AH increments and reduction in the myocardium oxygen demand. Thus, use of <<Lomir>> in a combined treatment of patients surviving myocardial infarction and suffering from AH, furthers reconvalescence and improves tolerability of physical loads.
Sledzevskaia
I K
IK
Golovkov
Iu Zh
IuZh
Kryzhanovskiĭ
V A
VA
D000368:Aged; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D017275:Isradipine / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D017202:Myocardial Ischemia / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology
D002121:Calcium Channel Blockers; D017275:Isradipine